histamine has been researched along with salmeterol xinafoate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (83.33) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, M; Whelan, CJ | 1 |
| Kohno, S; Ohata, K; Yamamura, H | 1 |
| Finnerty, JP; Harris, A; Holgate, ST; Palmer, J; Twentyman, OP | 1 |
| Grove, A; Lipworth, BJ | 1 |
| Bolliger, CT; Elsasser, S; Joos, L; Perruchoud, AP; Solèr, M | 1 |
| Johnson, M; Vardey, CJ; Whelan, CJ | 1 |
| Denyer, LH; Hassani, H; Maconochie, JG | 1 |
| Dahl, R; Larsen, BB; Pedersen, B; Venge, P | 1 |
| Jacques, LA; Lundback, B; Ringdal, N; Woolcock, A | 1 |
| Connelly, JC; Griffith, DE; Peterson, BT; Tate, RW | 1 |
| Grönneberg, R; Raud, J | 1 |
| Challiss, RA; Chilvers, ER; Lynch, BJ | 1 |
| Aikman, SL; Barnes, PJ; Harris, JG; Jensen, MW; O'Connor, BJ; Taylor, DA | 1 |
| Cheung, D; de GOEIJ, JA; de GRAAFF, CS; Steen, H; Sterk, PJ; Wever, AM | 1 |
| Petersen, LJ; Skov, PS | 1 |
| Barazzone-Argiroffo, C; Habre, W; Peták, F; Schütz, N; Sly, PD | 1 |
| De Peuter, S; Lemaigre, V; Smets, A; Van den Bergh, O; Verleden, GM | 1 |
| Bratke, K; Edner, A; Kuepper, M; Lindner, Y; Lommatzsch, M; Virchow, JC | 1 |
11 trial(s) available for histamine and salmeterol xinafoate
| Article | Year |
|---|---|
Protection against allergen-induced asthma by salmeterol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Female; Forced Expiratory Volume; Histamine; Humans; Male; Salmeterol Xinafoate; Time Factors | 1990 |
Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Forced Expiratory Volume; Histamine; Humans; Lung; Male; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Salmeterol Xinafoate | 1995 |
Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.
Topics: Adenosine Monophosphate; Adult; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Muscle, Smooth; Salmeterol Xinafoate; Time Factors | 1994 |
Dose-related protection against histamine-induced bronchoconstriction by inhaled salmeterol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Dose-Response Relationship, Drug; Histamine; Humans; Male; Maximal Expiratory Flow Rate; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate | 1994 |
The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Allergens; Asthma; Blood Proteins; Bronchial Provocation Tests; Double-Blind Method; Eosinophil Granule Proteins; Eosinophil-Derived Neurotoxin; Eosinophils; Female; Forced Expiratory Volume; Histamine; Humans; Leukocyte Count; Male; Ribonucleases; Salmeterol Xinafoate | 1993 |
Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Histamine; Humans; Lung; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate | 1996 |
Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late induration in human skin.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Antibodies, Anti-Idiotypic; Dose-Response Relationship, Drug; Female; Histamine; Humans; Injections, Intradermal; Male; Middle Aged; Premedication; Salmeterol Xinafoate; Terbutaline; Time Factors; Urticaria | 1996 |
Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Salmeterol Xinafoate | 1997 |
Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Double-Blind Method; Down-Regulation; Drug Interactions; Drug Tolerance; Female; Forced Expiratory Volume; Histamine; Humans; Male; Middle Aged; Placebos; Salmeterol Xinafoate; Theophylline | 1998 |
Effects of long-acting bronchodilators and placebo on histamine-induced asthma symptoms and mild bronchusobstruction.
Topics: Adult; Albuterol; Asthma; Bronchoconstriction; Bronchodilator Agents; Delayed-Action Preparations; Double-Blind Method; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Histamine; Histamine Agents; Humans; Male; Middle Aged; Salmeterol Xinafoate; Vital Capacity | 2006 |
Adverse effects of salmeterol in asthma: a neuronal perspective.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Asthma; Brain-Derived Neurotrophic Factor; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Histamine; Humans; Leukocytes, Mononuclear; Male; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Young Adult | 2009 |
7 other study(ies) available for histamine and salmeterol xinafoate
| Article | Year |
|---|---|
Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Capillary Permeability; Dinoprostone; Granulocytes; Guinea Pigs; Histamine; Lung; Male; Salmeterol Xinafoate; Skin | 1992 |
Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Depression, Chemical; Female; Guinea Pigs; Histamine; Histamine Release; In Vitro Techniques; Leukotriene B4; Lung; Male; Mast Cells; Passive Cutaneous Anaphylaxis; Peritoneal Cavity; Rats; Rats, Inbred Strains; Salmeterol Xinafoate; Serotonin; Skin; SRS-A | 1991 |
Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Bronchoalveolar Lavage Fluid; Ethanolamines; Formoterol Fumarate; Granulocytes; Guinea Pigs; Histamine; Humans; In Vitro Techniques; Infant, Newborn; Lung; Male; Neutrophils; Platelet Activating Factor; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Skin | 1993 |
Differential effects of salmeterol on lung endothelial and epithelial leakage in sheep.
Topics: Albuterol; Animals; Bronchodilator Agents; Endothelium; Epithelium; Histamine; Lung; Pulmonary Gas Exchange; Salmeterol Xinafoate; Sheep; Time Factors | 1996 |
Dissociation between beta-adrenoceptor-mediated cyclic AMP accumulation and inhibition of histamine-stimulated phosphoinositide metabolism in airways smooth muscle.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Albuterol; Animals; Bronchodilator Agents; Cattle; Culture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; Histamine; Muscle, Smooth; Phosphatidylinositols; Phosphodiesterase Inhibitors; Receptors, Adrenergic, beta; Respiratory System; Salmeterol Xinafoate | 1997 |
The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Allergens; Dermatitis, Allergic Contact; Female; Histamine; Humans; Inflammation Mediators; Male; Poaceae; Pollen; Prostaglandin D2; Regression Analysis; Salmeterol Xinafoate; Skin Tests; Time Factors | 1999 |
Prevention of bronchoconstriction in sensitized guinea pigs: efficacy of common prophylactic drugs.
Topics: Adrenergic Agonists; Adrenergic beta-2 Receptor Agonists; Albuterol; Allergens; Analysis of Variance; Androstadienes; Animals; Anti-Inflammatory Agents; Bronchial Hyperreactivity; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Cholinergic Antagonists; Cromolyn Sodium; Dose-Response Relationship, Drug; Drug Interactions; Fluticasone; Guinea Pigs; Histamine; Histamine H1 Antagonists; Ipratropium; Male; Methacholine Chloride; Ovalbumin; Salmeterol Xinafoate | 2004 |